INTERNATIONAL BIOTECHNOLOGY TRUST PLC - INSMED INC ownership

INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 254 filers reported holding INSMED INC in Q3 2023. The put-call ratio across all filers is 6.19 and the average weighting 0.3%.

Quarter-by-quarter ownership
INTERNATIONAL BIOTECHNOLOGY TRUST PLC ownership history of INSMED INC
ValueSharesWeighting
Q3 2023$1,012,124
+19.7%
40,1000.0%0.34%
+32.7%
Q2 2023$845,308
+23.9%
40,1000.0%0.26%
+35.3%
Q1 2023$682,101
-14.8%
40,1000.0%0.19%
-23.1%
Q4 2022$800,396
-7.4%
40,1000.0%0.25%
-10.8%
Q3 2022$864,000
-97.8%
40,100
+4969.5%
0.28%
-33.7%
Q2 2022$40,100,000
+181.1%
791
-98.0%
0.42%
-87.0%
Q1 2022$14,266,000
+332.4%
40,100
-66.9%
3.22%
+337.7%
Q4 2021$3,299,000
-50.3%
121,100
-49.8%
0.74%
-54.1%
Q3 2021$6,637,000
+133.0%
241,100
+140.9%
1.60%
+112.9%
Q2 2021$2,849,000
+149.0%
100,100
+197.9%
0.75%
+148.2%
Q1 2021$1,144,000
+2.2%
33,6000.0%0.30%
-1.0%
Q4 2020$1,119,000
+3.6%
33,6000.0%0.31%
-12.3%
Q3 2020$1,080,000
+19.7%
33,6000.0%0.35%
+16.3%
Q2 2020$902,000
+68.0%
33,6000.0%0.30%
+22.4%
Q1 2020$537,000
-33.0%
33,6000.0%0.24%
-15.2%
Q4 2019$801,000
-87.3%
33,600
-90.6%
0.29%
-90.1%
Q3 2019$6,287,000
-31.0%
356,6000.0%2.90%
-14.0%
Q2 2019$9,111,000
+184.9%
356,600
+224.2%
3.38%
+186.0%
Q1 2019$3,198,000110,0001.18%
Other shareholders
INSMED INC shareholders Q3 2023
NameSharesValueWeighting ↓
Asymmetry Capital Management, L.P. 250,584$4,420,0009.48%
Palo Alto Investors LP 7,239,649$127,707,0008.51%
Foresite Capital Management IV, LLC 1,429,518$25,217,0008.15%
First Light Asset Management, LLC 1,294,743$22,839,0003.45%
Foresite Capital Management II, LLC 915,016$16,141,0003.41%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 356,600$6,287,0002.90%
ACUTA CAPITAL PARTNERS, LLC 220,000$3,881,0002.80%
EMERALD ADVISERS, LLC 984,987$17,375,0000.81%
EMERALD MUTUAL FUND ADVISERS TRUST 911,936$16,087,0000.71%
Rock Springs Capital Management LP 890,000$15,700,0000.63%
View complete list of INSMED INC shareholders